Why is Link Pharma Chem falling/rising?
2025-11-28 00:27:17Recent Price Movement and Market Comparison Link Pharma Chem’s share price has been on a downward trajectory over multiple time frames. In the past week, the stock has fallen by 9.11%, sharply contrasting with the Sensex’s modest gain of 0.10%. Over the last month, the stock declined by 13.00%, while the Sensex rose by 1.11%. Year-to-date, the stock is down 23.63%, whereas the Sensex has gained 9.70%. This negative trend extends over the one-year and three-year periods, with the stock falling 24.32% and 24.46% respectively, while the Sensex posted gains of 6.84% and 37.61% over the same durations. Even over five years, despite a positive return of 43.62%, Link Pharma Chem has lagged the Sensex’s 94.16% growth substantially. Intraday Trading and Technical Indica...
Read MoreWhy is Link Pharma Chem falling/rising?
2025-11-14 22:38:52As of 14-Nov, Link Pharma Chem Ltd's stock price is currently at Rs 34.95, reflecting an increase of Rs 1.39 or 4.14%. The stock has opened with a gain today, outperforming its sector by 4.19%. It reached an intraday high of Rs 34.95 and has been trading in a narrow range of Rs 0.15. However, despite today's positive movement, the stock has shown a decline of 1.24% over the past month and a significant drop of 14.76% year-to-date. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 91.33% against the five-day average, indicating a potential concern regarding sustained interest in the stock. In the broader market context, Link Pharma Chem's short-term performance of +7.18% over the past week significantly outpaces the Sensex, which has only increased by 1.62% during the same period. However, the stock's longer-term performance remains weak, with decline...
Read More
Link Pharma Chem Q2 FY26: Profitability Collapses Amid Margin Erosion and Volume Decline
2025-11-14 09:23:33Link Pharma Chem Ltd., a micro-cap chemical manufacturer with a market capitalisation of ₹15.52 crores, reported deeply disappointing results for Q2 FY26, with net profit plummeting 95.00% quarter-on-quarter to just ₹0.02 crores from ₹0.40 crores in Q1 FY26. The company, which manufactures thionyl chloride and operates in the commodity chemicals segment, saw its profitability evaporate despite posting a marginal year-on-year revenue improvement of 31.04% to ₹6.29 crores.
Read MoreHow has been the historical performance of Link Pharma Chem?
2025-11-13 23:28:55Answer: The historical performance of Link Pharma Chem shows a declining trend in net sales and profitability over the past few years, culminating in losses in the most recent fiscal year. Breakdown: Link Pharma Chem's net sales have decreased from 53.56 Cr in March 2022 to 25.43 Cr in March 2025, reflecting a significant decline. The total operating income followed a similar trend, dropping from 53.56 Cr in March 2022 to 25.43 Cr in March 2025. The company's total expenditure also decreased, but not as sharply, leading to operating profits that turned negative in March 2024 and remained low at 0.31 Cr in March 2025. Profit before tax has been negative since March 2024, with a loss of 1.40 Cr reported in March 2025. Consequently, the profit after tax also showed losses, amounting to -1.03 Cr in March 2025. The company's total assets decreased from 32.46 Cr in March 2023 to 23.06 Cr in March 2025, while tot...
Read MoreWhen is the next results date for Link Pharma Chem?
2025-11-07 23:19:27Link Pharma Chem is scheduled to declare its results on 13 November 2025....
Read MoreWhy is Link Pharma Chem falling/rising?
2025-11-07 22:52:56As of 07-Nov, Link Pharma Chem Ltd is experiencing a decline in its stock price, currently at Rs 32.61, which reflects a decrease of Rs 2.35 or 6.72%. The stock has underperformed its sector by 5.65% today, having touched an intraday low of Rs 31.1, marking a significant drop of 11.04%. The stock has shown high volatility with an intraday volatility of 5.61% and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 40.52% compared to the 5-day average. The stock's performance over the past week and month shows a decline of 6.83%, while year-to-date, it has decreased by 20.46%. In the broader market context, the Sensex has only declined by 0.86% over the past week and has increased by 1.57% over the past month, indicating that Link Pharma Chem's performance is significantly ...
Read MoreAnnouncement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
28-Jan-2026 | Source : BSEDisclosure order Regulation 30 read with Part A of Schedule III of SEBI Regulation 2015 Demand order from Assistant Commissioner Central GST & Central Excise Vadodara FY 2021-22
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
12-Jan-2026 | Source : BSEWe are enclosed herewith the confirmation Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for quarter ended December 31 2025 received from M/s. MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited) RTA of the company.
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
01-Jan-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mangala Thakur
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available